IL2 and renal cell carcinoma: They treated three patients with metastatic RCC with the scFv(G250)-transduced-T cells in combination with human recombinant IL-2 and observed specific cytolysis of CAIX+ target cells and production of IFN-γ on stimulation with such cells in all patients.